title: Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs.
abstract: Sera from hemophiliacs were analyzed for antibodies to human immunodeficiency virus type 1 (HIV-1) by using radioimmunoprecipitation (RIP), western blotting (WB) with nonreducing buffer (NR), and WB with reducing buffer (R). We analyzed envelope gp160, gp120, and gp41; pol gene proteins p64, p53, and p34; and gag gene protein p24. Of 215 samples positive for reactivity to gp160 and gp120(RIP), antibodies to p24 were undetectable in 2 (0.9%), to gp41 in 9 (4.2%), to the pol antigens in 5 (2.3%), to gp120(NR) in 3 (1.4%), and to gp120(R) in 55 (25.6%). By sequential analysis of samples, antibodies to gp120(NR), gp120(R), p24, gp41, p64/53, and p34 were observed later in the course of infection than were antibodies to gp120(RIP) or gp160. This result suggests caution against reliance on WB as the "gold standard." A significantly higher rate of progression to AIDS-related complex was found for individuals lacking antibodies to gp120(R). It is possible that antigenic domains represented by gp120(R) may play a role in the pathogenesis of HIV-1 infection.
authors.affiliation: Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115.
authors.forename: M J
authors.initials: MJ
authors.lastname: Chou
authors.forename: T H
authors.initials: TH
authors.lastname: Lee
authors.forename: A
authors.initials: A
authors.lastname: Hatzakis
authors.forename: T
authors.initials: T
authors.lastname: Mandalaki
authors.forename: M F
authors.initials: MF
authors.lastname: McLane
authors.forename: M
authors.initials: M
authors.lastname: Essex
mesh_terms: D000386:AIDS-Related Complex / Q000150:complications / Q000276:immunology*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology*; D000914:Antibodies, Viral / Q000096:biosynthesis*; D011232:Chemical Precipitation; D004591:Electrophoresis, Polyacrylamide Gel; D006678:HIV / Q000276:immunology*; D006679:HIV Seropositivity / Q000276:immunology*; D006467:Hemophilia A / Q000150:complications / Q000276:immunology*; D006801:Humans; D008970:Molecular Weight; D013997:Time Factors; D014764:Viral Proteins / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D014764:Viral Proteins